AEOLUS PHARMACEUTICALS
Aeolus Pharmaceuticals, Inc. is developing its lead compound, AEOL-10150, as a treatment for the pulmonary and delayed effects of acute radiation exposure (“Lung-ARS” and “DEARE”). The Company’s development work is funded under a five year, $118 million, cost-plus contract with the Biomedical Advanced Research and Development Authority (“BARDA”), a division of the U.S. Department of Health and Human Services. BARDA is the Federal agency in charge of contracting for advanced development of drugs to treat radiological, biological and chemical threats for the civilian population. BARDA also manages the $2.8BB Special Reserve Fund for the purchase of these drugs for the U.S. Strategic National Stockpile.
AEOLUS PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1994-01-01
Address:
Mission Viejo, California, United States
Country:
United States
Website Url:
http://www.aolsrx.com
Total Employee:
1+
Status:
Active
Contact:
(949)481-9825
Email Addresses:
[email protected]
Total Funding:
18.51 M USD
Technology used in webpage:
SPF Domain Not Resolving ReCAPTCHA Contact Form 7 OVH
Similar Organizations
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Innovus Pharmaceuticals
Innovus Pharmaceuticals develops healthcare products for dermatology, autoimmune, respiratory, and sexual dysfunction diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Stock Details
Official Site Inspections
http://www.aolsrx.com
- Host name: 185.253.212.22
- IP address: 185.253.212.22
- Location: Poland
- Latitude: 52.2394
- Longitude: 21.0362
- Timezone: Europe/Warsaw
